There is no difference in safety and efficacy with Tirofiban or Eptifibatide for patients undergoing treatment of large vessel occlusion and underlying intracranial atherosclerosis

Publication date: March 2021Source: Interdisciplinary Neurosurgery, Volume 23Author(s): Hari Movva, Rani Rabah, Wondwossen Tekle, Alexandros Georgiadis, Laurie Preston, Hari Kotta, Ameer E. Hassan
Source: Interdisciplinary Neurosurgery - Category: Neurosurgery Source Type: research